Improving memory in Parkinson's disease: A healthy brain ageing cognitive training program

Movement Disorders

Volumn 28, Issue 8, 2013, Pages 1097-1103

  Naismith, Sharon L ^a   Mowszowski, Loren ^a   Diamond, Keri ^a   Lewis, Simon J G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cognitive training; Memory; Neuroplasticity; Parkinson's disease

Indexed keywords

AGED; AGING; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR RISK; COGNITION; CONTROLLED STUDY; DEPRESSION; EFFECT SIZE; FEMALE; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TRAINING;

COGNITIVE TRAINING; MEMORY; NEUROPLASTICITY; PARKINSON'S DISEASE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881552645     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25457     Document Type: Article

References (47)

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001;56:730-736.
2. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
3. Barone P, Aarsland D, Burn DJ, Emre M, Kulisevsky J, Weintraub D. Cognitive impairment in nondemented Parkinson's disease. Mov Disord 2011;26:2483-2495.
4. Muslimovic D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc 2009;15:426-437.
5. Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011;26:1814-1824.
6. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349-356.
7. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-1277.
8. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
9. Lewis SJ, Naismith SL. DASH to the InfoLine: Promoting a Healthy Brain and Mind in Parkinson's Disease. Sydney, Australia: Lifeblood; 2010.
10. Mowszowski L, Batchelor J, Naismith SL. Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique? Int Psychogeriatr 2010;22:537-548.
11. Valenzuela M, Sachdev P. Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry 2009;17:179-187.
12. Medalia A, Freilich B. The Neuropsychological Educational Approach to Cognitive Remediation (NEAR) model: practice principles and outcome studies. Am J Psychiatric Rehabil 2008;11:123-143.
13. Gates NJ, Sachdev PS, Fiatarone Singh MA, Valenzuela M. Cognitive and memory training in adults at risk of dementia: A systematic review. BMC Geriatr 2011;11:55.
14. Rebok GW, Carlson MC, Langbaum JBS. Training and maintaining memory abilities in healthy older adults: traditional and novel approaches. J Gerontol B Psychol Sci Soc Sci 2007;62(Spec No 1):53-61.
15. Norrie LM, Diamond K, Hickie IB, Rogers NL, Fearns S, Naismith SL. Can older "at risk" adults benefit from psychoeducation targeting healthy brain ageing? Int Psychogeriatr 2011;23:413-424.
16. Naismith SL, Diamond K, Carter PE, et al. Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program. Am J Geriatr Psychiatry 2011;19:240-248.
17. Naismith SL, Glozier N, Burke D, Carter PE, Scott E, Hickie IB. Early intervention for cognitive decline: is there a role for multiple medical or behavioural interventions? Early Interv Psychiatry 2009;3:19-27.
18. McGurk SR, Twamley EW, Sitzer DI, et al. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007;164:1791-1802.
19. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-1317.
20. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.
21. Oehlberg K, Barg FK, Brown GK, Taraborelli D, Stern MB, Weintraub D. Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study. J Geriatr Psychiatry Neurol 2008;21:123-132.
22. Muslimovic D, Schmand B, Speelman JD, de Haan RJ. Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc 2007;13:920-932.
23. Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinsons Dis 2012;2012:6.
24. Sinforiani E, Banchieri L, Zucchella C, Pacchetti C, Sandrini G. Cognitive rehabilitation in Parkinson's disease. Arch Gerontol Geriatr 2004;38(Suppl 9):387-391.
25. Mohlman J, Chazin D, Georgescu B. Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson's disease. J Geriatr Psychiatry Neurol 2011;24:91-97.
26. Sammer G, Reuter I, Hullmann K, Kaps M, Vaitl D. Training of executive functions in Parkinson's disease. J Neurol Sci 2006;248(1-2):115-119.
27. Paris AP, Saleta HG, de la Cruz Crespo Maraver M, et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Mov Disord 2011;26:1251-1258.
28. Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimageing. Front Neurol 2011;2:82.
29. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;51:745-752.
30. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
31. Fahn S, Elton R, Committee. UD. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-164.
32. Katzenschlager R, Hughes A, Evans A, et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord 2005;20:151-157.
33. Beck AT, Steer RA, Ranieri WF. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
34. Naismith SL, Pereira M, Shine JM, Lewis SJ. How well do caregivers detect mild cognitive change in Parkinson's disease? Mov Disord 2011;26:161-164.
35. Naismith SL, Redoblado-Hodge MA, Lewis SJ, Scott EM, Hickie IB. Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. J Affect Disord 2010;121:258-262.
36. Lee S, Redoblado-Hodge A, Naismith SL, Hermens DF, Porter MA, Hickie IB. Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric outpatients. Psychol Med 2012;14:1-13.
37. Wechsler DS. Wechsler Memory Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
38. Reitan RM. Manual for Administration for Neuropsychological Test Batteries for Adults and Children. Tucson, AZ: Reitan Neuropsychological Laboratory; 1979.
39. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2nd ed. New York: Oxford University Press; 1998.
40. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
41. Nelson HE, Willison J. National Adult Reading Test (NART): Test manual. 2nd ed. Windsor: UK: NFER-Nelson; 1991.
42. Naismith SL, Hickie IB, Lewis SJ. The role of mild depression in sleep disturbance and quality of life in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2010;22:384-389.
43. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011;10:819-828.
44. Emery VOB. Alzheimer's disease: are we intervening too late? J Neural Transm 2011;118:1361-1378.
45. Hogarty GE. Personal Therapy for Schizophrenia and Related Disorders. New York: Guilford Press; 2002.
46. Enciu AM, Nicolescu MI, Manole CG, Muresanu DF, Popescu LM, Popescu BO. Neuroregeneration in neurodegenerative disorders. BMC Neurol. 2011;11:75.
47. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-348.